言語を選択

HLA-A*0301 & B2M

HLA-A*0301 & B2M 製品リスト

属性
Protein (3)
製品ライブラリ
オンライン (3)
種
Human (3)
タグ
His Tag (2)His Tag & Avi Tag (1)
マーカー
PE Labeled (1)Unconjugated (1)Biotin-labeled (1)

製品番号	種	発現システム	製品説明
HLM-H52H3	Human	HEK293	Human HLA-A*03:01&B2M Monomer Protein (Peptide free, MALS verified)
HLM-H82Ey	Human	HEK293	Biotinylated Human HLA-A*03:01&B2M Monomer Protein (Peptide free, MALS verified)
HLM-HP2H6	Human	HEK293	PE-Labeled Human HLA-A*03:01&B2M Tetramer Protein (Peptide free)

総数量3

HLA-A*0301 & B2Mバックグランド

Major histocompatibility complex (MHC), group of genes that code for proteins found on the surfaces of cells that help the immune system recognize foreign substances. MHC proteins are found in all higher vertebrates. In human beings the complex is also called the human leukocyte antigen (HLA) system.

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Vopratelimab	JTX-2011	Phase 2 Clinical	Jounce Therapeutics Inc	Neoplasms; Carcinoma, Non-Small-Cell Lung	詳細
Izuralimab	XmAb-23104; XmAb-104	Phase 2 Clinical	Xencor Inc	Sarcoma; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Endometrial Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms	詳細
Feladilimab	GSK-609; GSK-3359609	Phase 2 Clinical	Glaxosmithkline Plc	Head and Neck Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Multiple Myeloma	詳細
Alomfilimab	KY-1044	Phase 2 Clinical	Kymab Ltd	Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Pancreatic Neoplasms; Melanoma; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis	詳細
Acazicolcept	ALPN-101	Phase 2 Clinical		Graft vs Host Disease; Autoimmune Diseases; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Inflammation	詳細
MEDI-570		Phase 1 Clinical	Japan Tobacco (Hong Kong) Ltd	Lymphoma, Follicular; Lupus Erythematosus, Systemic; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Mycosis Fungoides	詳細
Anti-ICOS (Bristol Myers Squibb)	BMS-986226	Phase 1 Clinical	Bristol-Myers Squibb Company	Neoplasms	詳細